25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35222709 | Combination treatment with sorafenib and wh-4 additively suppresses the proliferation of liver cancer cells. | 2022 Mar | 1 |
2 | 35241510 | Combination Treatment of Sorafenib and Bufalin Induces Apoptosis in NCI-H292 Human Lung Cancer Cells In Vitro. | 2022 Mar-Apr | 1 |
3 | 34076978 | Long noncoding RNA NEAT1 aggravates sorafenib-resistance in non-small cell lung cancer via regulating miRNA-335/c-Met. | 2021 Mar-Apr | 1 |
4 | 29156516 | Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. | 2018 Jan | 1 |
5 | 29959200 | Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells. | 2018 Sep | 1 |
6 | 27632413 | Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells. | 2017 Jan | 2 |
7 | 27807662 | C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. | 2017 Feb | 1 |
8 | 28154184 | Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma. | 2017 Apr 21 | 1 |
9 | 28476378 | Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma. | 2017 Jun | 1 |
10 | 27484637 | Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy. | 2016 Oct | 1 |
11 | 25451688 | Oncogenic c-Myc and prothymosin-alpha protect hepatocellular carcinoma cells against sorafenib-induced apoptosis. | 2015 Jan 1 | 1 |
12 | 25683251 | Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib. | 2015 May | 1 |
13 | 24213303 | Stimulatory effects of sorafenib on human non‑small cell lung cancer cells in vitro by regulating MAPK/ERK activation. | 2014 Jan | 1 |
14 | 24402682 | ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells. | 2014 Mar | 1 |
15 | 24571452 | ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells. | 2014 Jul | 2 |
16 | 24989014 | Differential combined effect of COX inhibitors on cell survival suppressed by sorafenib in the HepG2 cell line. | 2014 | 1 |
17 | 25136776 | Sorafenib regulating ERK signals pathway in gastric cancer cell. | 2014 Sep | 1 |
18 | 21604268 | Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. | 2012 Apr | 1 |
19 | 22446485 | Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. | 2012 Jun 21 | 1 |
20 | 22689683 | The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status. | 2012 Nov | 1 |
21 | 20197401 | Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. | 2010 Mar | 1 |
22 | 19366808 | Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway. | 2009 May 1 | 1 |
23 | 19483105 | BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing. | 2009 Aug | 2 |
24 | 18200035 | Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway. | 2008 Apr | 2 |
25 | 18765530 | Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. | 2008 Sep 1 | 1 |